Australia will ban pharmacies from creating replicas of popular weight loss drugs like Ozempic, following reports of dangerous side effects, including one patient’s hospitalization for a “serious adverse incident.” Pharmacies will be restricted from making GLP-1 receptor agonist products — a class of drugs that help manage blood sugar levels — for individual patients, Health…